ALPMF - Astellas Pharma Inc. (ALPMF) CEO Kenji Yasukawa on Q4 2021 Results - Earnings Call Transcript
Astellas Pharma, Inc. (ALPMF) Q4 2021 Earnings Conference Call April 27, 2021 1:00 AM ET Company Participants Kenji Yasukawa - President & CEO Naoki Okamura - Corporate EVP, Chief Strategy Officer and CFO Yukio Matsui - Chief Commercial Officer Bernie Zeiher - Chief Medical Officer Conference Call Participants Hidemaru Yamaguchi - Citigroup Securities Kazuaki Hashiguchi - Daiwa Securities Fumiyoshi Sakai - Credit Suisse Securities Seiji Wakao - JP Morgan Securities Motoya Kohtani - Nomura Securities Shinichiro Muraoka - Morgan Stanley MUFJ Securities Presentation Kenji Yasukawa Hello, everyone, Yasukawa speaking. Again, thank you very much for participating in our financial results announcement meetings, despite your busy schedule. I'm sure you have the materials at hand, as we mentioned on the page number, as I explained. Page 2 is a cautionary statement regarding forward-looking information. I'm not going to read. Page 3 is the agenda today. As usual, I will explain the
For further details see:
Astellas Pharma, Inc. (ALPMF) CEO Kenji Yasukawa on Q4 2021 Results - Earnings Call Transcript